Overview

A Study to Evaluate Pharmacokinetics (PK) of Etrumadenant Tablet and Capsule Formulations in Healthy Adult Participants

Status:
Recruiting
Trial end date:
2022-03-17
Target enrollment:
Participant gender:
Summary
This study will compare the pharmacokinetics (PK) effect of single-dose etrumadenant tablet and capsule formulations in fasted conditions. The effect of food on single-dose PK of tablet formulation will also be assessed.
Phase:
Phase 1
Details
Lead Sponsor:
Arcus Biosciences, Inc.